Editorial Board for section 'Drug Targeting and Design'
- Nanomedicine and Nanotechnology Section
- Pharmaceutical Technology, Manufacturing and Devices Section
- Physical Pharmacy and Formulation Section
- Biopharmaceutics Section
- Drug Delivery and Controlled Release Section
- Pharmacokinetics and Pharmacodynamics Section
- Gene and Cell Therapy Section
- Drug Targeting and Design Section
- Biologics and Biosimilars Section
- Clinical Pharmaceutics Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
School of Life Sciences, Nanjing University, Nanjing 210093, China
Interests: chemical biology; medicinal bioinorganic chemistry; anticancer drug; anti-Alzheimer's disease drug; drug design; mechanism of action; platinum-based anticancer drug
Interests: chemical biology; medicinal bioinorganic chemistry; anticancer drug; anti-Alzheimer's disease drug; drug design; mechanism of action; platinum-based anticancer drug
Molecular Imaging & Radiochemistry, Medical Faculty Mannheim of Heidelberg University, 68167 Mannheim, Germany
Interests: radiolabeling strategies; radiotracer development; development of contrast agents for PCCT
Special Issues, Collections and Topics in MDPI journals
Interests: radiolabeling strategies; radiotracer development; development of contrast agents for PCCT
Special Issues, Collections and Topics in MDPI journals
Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 0W6, Canada
Interests: radio-diagnosis and therapy; targeted drug delivery; nuclear medicine; radiopharmaceutical techniques
Special Issues, Collections and Topics in MDPI journals
Interests: radio-diagnosis and therapy; targeted drug delivery; nuclear medicine; radiopharmaceutical techniques
Special Issues, Collections and Topics in MDPI journals
Department of Oncology, University of Alberta, 6820 116 Street, Edmonton, AB T6G 2R3, Canada
Interests: imaging biomarkers; radiopharmaceuticals
Special Issues, Collections and Topics in MDPI journals
Interests: imaging biomarkers; radiopharmaceuticals
Special Issues, Collections and Topics in MDPI journals
School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China
Interests: targeted antiviral and anticancer drug discovery; diversity-oriented synthesis and rational drug design for chemical biology and drug discovery; discovery of novel SERMs, SERDs and PROTACs to improving therapeutics that target the estrogen receptor
Interests: targeted antiviral and anticancer drug discovery; diversity-oriented synthesis and rational drug design for chemical biology and drug discovery; discovery of novel SERMs, SERDs and PROTACs to improving therapeutics that target the estrogen receptor
Institute of Applied Biotechnology, University of Applied Science Biberach, 88400 Biberach, Germany
Interests: CNS drug delivery; intranasal delivery; hydrogels for mucosal delivery; antibody and protein engineering; delivery of monoclonal antibodies; safety and immune interaction; assay and model development (in vitro, ex vivo and in vivo); proof-of concept studies; mechanism-of-action studies; neurodegenerative diseases; neurobiology
Interests: CNS drug delivery; intranasal delivery; hydrogels for mucosal delivery; antibody and protein engineering; delivery of monoclonal antibodies; safety and immune interaction; assay and model development (in vitro, ex vivo and in vivo); proof-of concept studies; mechanism-of-action studies; neurodegenerative diseases; neurobiology
Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden
Interests: antibody engineering; antibody; chemical conjugation; radionuclide molecular imaging; radiopharmaceuticals; alternative scaffolds proteins; protein engineering; in tumor targeting
Interests: antibody engineering; antibody; chemical conjugation; radionuclide molecular imaging; radiopharmaceuticals; alternative scaffolds proteins; protein engineering; in tumor targeting
